Getting to the Heart of Cardiovascular Research: From Yesterday to Today and Looking Towards Tomorrow
Dr. Melanie White presents the various methods for assessing cardiac function in the context of pathology, spanning from in vitro to in vivo techniques, and how she integrates these with cutting-edge mass spectrometry in her research on cardiovascular disease pathogenesis.
#ExpertAnswers: Jeffrey Silva and Matthew Stokes on Mass Spectrometry-Based Proteomics
Experts from Cell Signaling Technology answer questions from a recent webinar on mass spectrometry-based proteomics.
Targeting Proteomics to Decipher Biology for the Drug Development Pipeline
Dr. Jeffrey Silva explores the role of mass spectrometry-based proteomics on drug discovery, disease mechanisms, and biomarker identification.
#ExpertAnswers: Ejvind Mørtz on Protein Analysis
Ejvind Mørtz discusses the benefits and applications of mass spectrometry (MS)-based host cell protein (HCP) analysis and why HCP ELISAs are insufficient for documenting product-related impurities.
Rethink your Impurity Analysis Strategy
In this webinar, Dr. Ejvind Mørtz discusses the benefits and applications of mass spectrometry (MS)-based host cell protein (HCP) analysis and why HCP ELISAs are insufficient for documenting product-related impurities. Watch to learn where to apply the assay in a typical process and what you gain from deploying it to your workflow.
Plasma Proteomics: The Next Frontier of Biomarker Discovery in the Precision Medicine Era
Plasma proteomics is increasingly recognized as a fundamental approach to accelerate biomarker discovery and drug development, taking precision medicine to the next level.
Streamlining Process Monitoring in Cell Culture Analysis & Spectrometry
Daniel Merriman, Femi Egbebi and Krzysztof Inglot discuss research solutions offered by Thermo Fisher Scientific regarding cell culture analysis, spectrometry and other topics within the biopharma field.
